Global Blood Story

Global Blood Therapeutics Inc -- USA Stock  

USD 32.55  0.35  1.06%

Macroaxis does not monitor all media channels or aggregates social signals for Global Blood. But even though we do not provide professional-grade financial sentiment analysis on Global Blood Therape, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Global Blood. Please also check Global Blood Hype Analysis, Global Blood Correlation and Global Blood Performance
Global Blood Therapeutic Acquisition Value Could Be At Least 3 Billion
Global Blood Therapeutics Inc is in the process of developing GBT440 to reduce the severity and frequency of crises and pain associated with sickle cell disease and to improve blood oxygenation characteristics and quality of life for ... The Global Blood Therapeutics Inc Downgraded to Sell at Zacks Investment ... Petro Global News 24 Global Blood Therapeutics Inc Receive News and Ratings Daily BBNS

Read More...   

Story Momentum

This article from www.benzinga.com published on 20 of March contributed to the next trading period closing price depreciation.The overall trading delta to the next next day price was 2.81% . The overall trading delta when the story was published to current price is 12.45% .

Similar stores for Global Blood

few days ago at http://globenewswire.com 
Global Blood Therapeutics Announces Presentation of New Data Showing Positive ...
news
GlobeNewswire - Oct 11, 2017 SOUTH SAN FRANCISCO, Calif., Oct. 11, 2017 -- Global Blood Therapeutics, Inc. today announced the presentation of a case study highlighting the effect of GBT440 on markers of anemia and hemolysis the ... Global Blood Therapeutics, Inc. Given a 53.00 Price Target at ... - StockNewsTimes Interested In The Healthcare Industry Take A Look At Global Blood ... - Simply Wall St
over a month ago at http://www.equities.com 
Global Blood Therapeutics Inc. Soars 6.19 percent on August 28
Equities News
Global Blood Therapeutics Inc. had a good day on the market for Monday August 28 as shares jumped 6.19 percent to close at 29.15. Shares Running on Volume Global Blood Therapeutics Inc. - Financial Newsweek Brokerage Analyst Buys Global Blood Therapeutics Inc. and ... - Rives Journal
over three months ago at http://www.prnewswire.com 
Research Reports Coverage on Biotech Stocks -- Editas Medicine, Global Blood ...
prnewswire News
Stock-Callers.com has issued today research reports on Editas Medicine Inc. , Global Blood Therapeutics Inc. , Geron Corp. , and Infinity Pharmaceuticals Inc. . Biotech companies produce ...

Did you try this?

Run Money Flow Index Now
   

Money Flow Index

Determine momentum by analyzing Money Flow Index and other technical indicators
Hide  View All  Next  Launch Money Flow Index

Shares Owned by Insiders

Shares Owned by Insiders Comparative Analysis
  Shares Owned by Insiders 
      Global Blood Comparables 
Global Blood is currently under evaluation in shares owned by insiders category among related companies. Shares Owned by Insiders show percentage of outstanding shares owned by insiders (such as key officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.